ICD-10 Coding for Myelodysplastic Syndromes(C92.0, C92.0P, D46.0)

Explore detailed ICD-10 coding guidelines for myelodysplastic syndromes, including specific subtypes and documentation requirements.

Also known as:
MDSPreleukemia
Related ICD-10 Code Ranges

Complete code families applicable to Myelodysplastic Syndromes

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
D46.9Myelodysplastic syndrome, unspecified
D46.1Refractory anemia with ring sideroblasts
D46.2Refractory anemia with excess blasts

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information

Essential facts and insights aboutMyelodysplastic Syndromes

Differential Codes

Alternative codes to consider when ruling out similar conditions

Acute myeloid leukemiaC92.0
Sideroblastic anemiaD64.0

Documentation & Coding Risks

Avoid these common issues when documenting Myelodysplastic Syndromes.

Failing to document the specific subtype of MDS.

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding guidelines., Financial: Potential for reduced reimbursement.

Mitigation

Ensure all diagnostic tests are documented., Regularly update the patient's medical record with new findings.

Using unspecified codes when specific subtype information is available.

Impact

Reimbursement: Potential for reduced reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines requiring specificity., Data Quality: Decreased data quality and accuracy in patient records.

Mitigation

Ensure documentation supports the use of specific codes by including subtype details.

Specificity in Coding

Impact

Risk of audits due to use of unspecified codes when specific information is available.

Mitigation

Ensure documentation supports the use of specific codes.

Frequently Asked Questions